Results 211 to 220 of about 313,710 (255)

Tyrosine kinase inhibitors

2001
FRALEY MARK E, HAMBAUGH SCOTT R, HUNGATE RANDALL W   +2 more
openaire   +9 more sources

Clinical pharmacokinetics of tyrosine kinase inhibitors

Cancer Treatment Reviews, 2009
Hans J. Gelderblom, Henk-Jan Guchelaar, Nielka P van Erp   +2 more
exaly  

Raman Microspectroscopic Evidence for the Metabolism of a Tyrosine Kinase Inhibitor, Neratinib, in Cancer Cells

Angewandte Chemie - International Edition, 2018
Samir F El-Mashtoly, Klaus Gerwert, Hesham K. Yosef   +2 more
exaly  

Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy

Cancers, 2020
Nor Eddine Sounni, Charles Pottier, Guy Jerusalem   +2 more
exaly  

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?

Trends in Endocrinology and Metabolism, 2015
Athanasios Fountas, Agathocles Tsatsoulis   +1 more
exaly  

Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors

International Journal of Molecular Sciences, 2018
Matthew J Vergne, Klarissa D Jackson, Rebecca Durandis   +2 more
exaly  

Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3

Bioorganic and Medicinal Chemistry Letters, 2006
Michael P Clark, Biswanath De, Steven K Laughlin   +2 more
exaly  

Inhibitors of Bruton's tyrosine kinase

2010
BERTHEL STEVEN, FIROOZNIA FARIBORZ, FISHLOCK DANIEL, HONG JUN-BAE, LOU YAN, LUCAS MATTHEW, OWENS TIMOTHY D, SARMA KESHAB, SWEENEY ZACHARY KEVIN, TAYGERLY JOSHUA PAUL GERGELY   +9 more
  +12 more sources

Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies

International Journal of Molecular Sciences, 2014
Mohammad Hojjat-Farsangi
exaly  

TYROSINE KINASE INHIBITORS

2012
GOLDSTEIN DAVID MICHAEL, BRAMELD KENNETH ALBERT   +1 more
openaire   +3 more sources